Latuda朗舒達

Latuda Indications/Uses

Manufacturer:

Sunovion

Distributor:

DKSH
Full Prescribing Info
Indications/Uses
Schizophrenia: LATUDA is indicated for the treatment of patients with schizophrenia.
The efficacy of LATUDA in schizophrenia was established in five 6-week controlled studies of adult patients with schizophrenia (see Pharmacology: Pharmacodynamics: Clinical Studies under Actions).
The effectiveness of LATUDA for longer-term use, that is, for more than 6 weeks, has not been established in controlled studies. Therefore, the physician who elects to use LATUDA for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient (see Dosage & Administration).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in